🇺🇸 ABBV — AbbVie Inc.

Healthcare Compra
← Volver

Precio actual

256,46 USD

Máx. histórico

267,47

37 días

Caída desde máximo

-4,12%

Rango 52 semanas

190,75 – 267,47

Variación hoy

-1,44%

Cierre anterior

260,21

Rango de hoy

255,61 – 258,91

Volumen hoy

4.701.126

Información
Nombre completo
AbbVie Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
57.000
PER ⓘ
72,45 (puede no estar actualizado)
Dividend yield
2,70% (puede no estar actualizado)
Precio objetivo analistas
276,59 USD (puede no estar actualizado)
Primera cotización
02/01/2013
Precio actualizado
hace 1 día
Sobre la empresa

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's feet, forehead lines, and platysma bands; Juvederm Collection to treat volume loss in the temples, undereye, cheeks, chin, lips and lower face; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; Qulipta for episodic and chronic migraine; and Vyalev for the treatment of motor fluctuations, as well as Botox Therapeutic to treat chronic migraine, overactive bladder, spasticity, cervical dystonia, and other conditions. In addition, the company offers Ozurdex for visual impairment; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; and other eye care products, including Refresh/Optive, Xen, Durysta, and Restasis. Further, it provides Mavyret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Dividendos repartidos Total últimos 12 meses: 6,8300 USD · Yield: 2,66%
Fecha de pago Importe por participación
13/10/2022 1,4100 USD
14/07/2022 1,4100 USD
13/04/2022 1,4100 USD
13/01/2022 1,4100 USD
14/10/2021 1,3000 USD
14/07/2021 1,3000 USD
14/04/2021 1,3000 USD
14/01/2021 1,3000 USD
14/10/2020 1,1800 USD
14/07/2020 1,1800 USD
14/04/2020 1,1800 USD
14/01/2020 1,1800 USD
11/10/2019 1,0700 USD
12/07/2019 1,0700 USD
12/04/2019 1,0700 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/08/2016 65,04 65,43 64,27 64,72 -0,52% 1,78% 6.379.000
24/08/2016 66,31 66,53 64,84 65,06 -1,68% 2,55% 8.551.100
23/08/2016 67,26 67,49 65,99 66,17 -1,25% 2,23% 10.227.800
22/08/2016 67,31 67,79 66,92 67,01 -0,13% 1,29% 7.884.800
19/08/2016 66,57 67,18 66,51 67,10 +0,49% 1,01% 6.709.400
18/08/2016 66,57 67,43 66,55 66,77 -0,09% 1,32% 8.205.800
17/08/2016 66,69 67,35 66,35 66,83 +0,13% 1,50% 7.945.400
16/08/2016 67,13 67,61 66,50 66,74 -0,96% 1,65% 7.147.600
15/08/2016 67,47 68,12 67,32 67,39 +0,30% 1,19% 5.215.400
12/08/2016 66,86 67,39 66,55 67,19 +0,36% 1,26% 5.215.400
11/08/2016 66,86 67,11 66,70 66,95 +0,78% 0,61% 4.246.600
10/08/2016 66,70 66,96 66,19 66,43 -0,49% 1,15% 4.506.100
09/08/2016 66,34 67,25 66,25 66,76 +0,63% 1,51% 5.717.300
08/08/2016 66,38 66,67 65,75 66,34 -0,30% 1,39% 5.309.300
05/08/2016 66,15 66,60 66,12 66,54 +0,67% 0,73% 5.045.600
04/08/2016 66,58 66,98 66,08 66,10 -0,71% 1,35% 4.901.900
03/08/2016 66,81 67,00 66,22 66,57 -0,31% 1,17% 6.355.100
02/08/2016 66,93 67,06 66,05 66,78 -0,24% 1,51% 8.763.200
01/08/2016 66,23 67,08 66,23 66,94 +1,07% 1,28% 7.599.000
29/07/2016 65,27 66,40 65,15 66,23 +2,33% 1,92% 10.525.000
28/07/2016 64,79 65,06 63,93 64,72 -0,28% 1,74% 6.556.100
27/07/2016 64,42 65,11 64,32 64,90 +0,70% 1,23% 6.220.400
26/07/2016 64,41 64,73 63,96 64,45 +0,20% 1,20% 4.885.200
25/07/2016 63,91 64,50 63,71 64,32 +0,80% 1,24% 7.241.200
22/07/2016 64,00 64,09 63,58 63,81 -0,13% 0,80% 4.972.900
21/07/2016 63,23 64,00 63,17 63,89 +0,76% 1,31% 6.145.500
20/07/2016 63,57 63,90 63,33 63,41 +0,14% 0,90% 7.502.800
19/07/2016 63,41 63,97 63,09 63,32 -0,38% 1,39% 5.794.500
18/07/2016 63,23 63,77 63,18 63,56 +0,38% 0,93% 6.384.800
15/07/2016 63,82 64,17 63,13 63,32 -0,47% 1,63% 8.827.500